Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99,605,545
-
Total 13F shares
-
88,956,333
-
Share change
-
+4,870,059
-
Total reported value
-
$7,509,818,200
-
Put/Call ratio
-
64%
-
Price per share
-
$84.43
-
Number of holders
-
295
-
Value change
-
+$405,236,838
-
Number of buys
-
150
-
Number of sells
-
148
Institutional Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q2 2019
As of 30 Jun 2019,
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) was held by
295 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
88,956,333 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., Capital International Investors, PERCEPTIVE ADVISORS LLC, Bellevue Group AG, PRICE T ROWE ASSOCIATES INC /MD/, HealthCor Management, L.P., and STATE STREET CORP.
This page lists
295
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.